Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sugen files IND for angiogenesis inhibitor

July 3, 1997

ACT licenses rights to patents related to dendritic cell therapy

July 3, 1997

Kyowa Hakko discovers antitumor compounds in Streptomyces culture

July 3, 1997

PN-401: a new uridine prodrug from Pro-Neuron

July 1, 1997

Lisofylline not associated with reduction in high-dose IL-2 toxicity

June 30, 1997

Advisory committee recommends Taxol for KS

June 27, 1997

PEG-rHuMGDF enhances platelet recovery in cancer patients undergoing chemotherapy

June 27, 1997

Cytel and Baxter enter research agreement for the development of ex vivo cancer therapy

June 27, 1997

MDR-reversing agent from Mitsui Toatsu characterized in vitro and in vivo

June 27, 1997

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

June 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...